Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Mallinckrodt
Citi
US Army
Queensland Health
Accenture
Boehringer Ingelheim
UBS
McKesson

Generated: October 19, 2017

DrugPatentWatch Database Preview

Acetaminophen; aspirin; caffeine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for acetaminophen; aspirin; caffeine and what is the scope of acetaminophen; aspirin; caffeine patent protection?

Acetaminophen; aspirin; caffeine
is the generic ingredient in two branded drugs marketed by Glaxosmithkline Cons and Perrigo, and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Acetaminophen; aspirin; caffeine has thirteen patent family members in thirteen countries.

There are sixty-six drug master file entries for acetaminophen; aspirin; caffeine. Thirty-six suppliers are listed for this compound.

Summary for Generic Name: acetaminophen; aspirin; caffeine

US Patents:1
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: see list66
Suppliers / Packagers: see list36
Bulk Api Vendors: see list2
Clinical Trials: see list1,953
Patent Applications: see list4
Drug Prices:see low prices
DailyMed Link:acetaminophen; aspirin; caffeine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo
ACETAMINOPHEN, ASPIRIN AND CAFFEINE
acetaminophen; aspirin; caffeine
TABLET;ORAL075794-001Nov 26, 2001OTCNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline Cons
EXCEDRIN (MIGRAINE)
acetaminophen; aspirin; caffeine
TABLET;ORAL020802-001Jan 14, 1998OTCYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: acetaminophen; aspirin; caffeine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Cons
EXCEDRIN (MIGRAINE)
acetaminophen; aspirin; caffeine
TABLET;ORAL020802-001Jan 14, 1998► Subscribe► Subscribe
Glaxosmithkline Cons
EXCEDRIN (MIGRAINE)
acetaminophen; aspirin; caffeine
TABLET;ORAL020802-001Jan 14, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: acetaminophen; aspirin; caffeine

Country Document Number Estimated Expiration
Spain2198725► Subscribe
Argentina016337► Subscribe
Taiwan565447► Subscribe
Germany69814636► Subscribe
Canada2296492► Subscribe
Malaysia121730► Subscribe
World Intellectual Property Organization (WIPO)9903475► Subscribe
Denmark0994714► Subscribe
South Africa9806219► Subscribe
European Patent Office0994714► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chinese Patent Office
Deloitte
Accenture
Farmers Insurance
UBS
Boehringer Ingelheim
Argus Health
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot